23:49 , Jun 6, 2019 |  BC Extra  |  Company News

Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico

Grail Inc. (Menlo Park, Calif.) hired Hans Bishop as CEO to succeed Jennifer Cook, who also stepped down from the cancer diagnostic company's board, citing family health reasons. Bishop, who has been on Grail’s board...
00:05 , May 20, 2017 |  BioCentury  |  Strategy

Henri: N of 1

Gaucher’s disease had swollen Brian Berman’s spleen to the size of a basketball and physicians at NIH told the three-year-old’s parents that it had to be removed. It was 1984, there was no effective treatment...
00:49 , Mar 8, 2017 |  BC Extra  |  Company News

Management tracks

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said Chairman Leonard Bell will retire from its board, effective May 10. Fosun Kite Biotechnology Co. Ltd., a JV between Kite Pharma Inc. (NASDAQ:KITE) and Shanghai Fosun Pharmaceutical Group Co. Ltd....
01:23 , Feb 22, 2017 |  BC Extra  |  Company News

BMS gains on investment rumors

Bristol-Myers Squibb Co. (NYSE:BMY) declined to comment on media reports that activist investor Carl Icahn has taken a stake in the company. The rumors drove BMS shares as high as $56.79 during the day on...
08:00 , Dec 17, 2015 |  BC Innovations  |  Strategy

San Diego ceiling

A decade ago, San Diego sat poised to compete with Boston and San Francisco as one of the nation's top biotech hubs, with Biocom , the local industry organization, making a priority of luring investors...
02:25 , Apr 14, 2015 |  BC Extra  |  Company News

Management tracks

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) hired Ramona Sequeira as president of its U.S. business unit. She succeeds Doug Cole, who stepped down March 31. Sequeira was VP of Lilly USA at Eli Lilly and Co....
08:00 , Feb 2, 2015 |  BioCentury  |  Politics, Policy & Law

Dr. Califf goes to Washington

FDA has had three deputy commissioners during the Obama administration ; each was expected to play a major role in shaping the agency, and none of them lived up to expectations. Last week's announcement that...
08:00 , Nov 24, 2014 |  BC Week In Review  |  Company News

Retrophin management update

Retrophin Inc. (NASDAQ:RTRX), New York, N.Y.   Business: Renal, Musculoskeletal, Pulmonary   Hired: Laura Clague as SVP and CFO, formerly CFO of San Diego and Ohio operations at Amylin Pharmaceuticals Inc. , which Bristol-Myers Squibb...
03:27 , Nov 7, 2014 |  BC Extra  |  Company News

Aegerion buys Myalept from AZ for $325M

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) acquired global rights outside of three Asian territories to Myalept metreleptin from AstraZeneca plc (LSE:AZN; NYSE:AZN) for $325 million up front. The transaction is expected to close in January 2015. In...
07:00 , Sep 15, 2014 |  BC Week In Review  |  Company News

AstraZeneca sales and marketing update

AstraZeneca launched Bydureon Pen for self-injection of once-weekly Bydureon exenatide in the U.S. to treat Type II diabetes. In March, FDA approved the pen, which contains the same formulation and dose as the single-dose tray...